ABCC3 and glioma: To investigate the prognostic value of the expression of ABCC3 in glioma patients, our team performed univariable Cox analyses and observed that ABCC3 (HR = 1.369; 95% CI = 1.306–1.435; P < 0.001), PRS types, histological status, gradation, ages, and chemotherapy were factors related to higher risks and IDH variant and 1p19q codeletion were related to lower risks (Figure 3(a)).